- Virtual clinic technology can change the treatment approach for patients who live far from necessary medical care or who are burdened by visiting the doctor in person The NeuroSphere Virtual Clinic ...

ABBOTT PARK, Ill., May 2, 2022 /CSRwire/ - Abbott (NYSE: ABT) today announced that it has launched an upgraded version of its NeuroSphere™ myPath™ digital health app with enhanced functionality that ...

(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that remote Neuromodulation Patient-Care Technology, NeuroSphere Virtual Clinic, has received the Health Canada licencing. The neuromodulation ...

EXCLUSIVE: William Mundell’s Neurosphere Entertainment has acquired film and TV rights to The Lucky Ones: One Family and the Extraordinary Invention of Chinese America, historian Mae Ngai’s work of ...

Using the programmer app, clinicians are able to remotely prescribe new treatment settings to the patient’s neuromodulation device via cloud and Bluetooth-based technology. The Food and Drug ...

This article may contain links from our affiliate and advertising partners. We may receive payments when you click on links, buy through them or share this content. Kim Ballesty, a mother of three, ...

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) said Thursday it will launch NeuroSphere myPath, a digital health app designed to track and report on patient perceived pain relief and general well ...

Abbott Laboratories has won the U.S. FDA’s nod for an iOS-compatible app that is designed to optimize care for people using the company’s neuromodulation devices to manage their chronic pain and ...

Reelin expression is reduced in various regions in the post-mortem brain of schizophrenia patients but the exact role of reelin function in the neurobiology of schizophrenia remains elusive. Absence ...

Abbott (NYSE: ABT) today announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and ...